Greenovation´s BryoTechnology Substantially Improves Yields of Pharmaceutical Proteins
News Oct 25, 2016
GREENOVATION has substantially enhanced the yields of pharmaceutical proteins produced using its moss-based BryoTechnology. Targeted genetic modifications, improved fermentation procedures and optimized production processes mean that the new and highly productive BryoMaster® cell lines can secrete higher yields of complex molecules directly into the culture medium.
This includes producing antibodies in their active form, with enhanced antibody-dependent cell mediated cytoxity (ADCC). Adding in the company's BryoSpeed® technology means that Greenovation can produce sufficient protein for quality assessment within only seven days.
“Our intensive research efforts are now bearing fruit” says Dr. Thomas Frischmuth, CEO of Greenovation. “The recent yield improvements once again underline the viability of moss-based cGMP-production as a beneficial alternative to mammalian cells in steel-tanks.”
The moss-made proteins manufactured using Greenovation's BryoTechnology have very high levels of glycan consistency and batch-to-batch stability. Combining the reliability of the production process and the ease of the modular single use-based approach means that BryoTechnology is prepared to face production challenges of the facility of the future.
Low Temperatures Turn Stem Cells into Calorie-Burning FatNews
The secret to healthy eating may not be in freezer food, but low temperatures can help turn stem cells into brown fat, a type of fat which helps burn calories. A new study could turn this knowledge into weight-loss treatments.READ MORE
Chemicals in Lavender and Tea Tree Oil Could be Hormone DisruptorsNews
A new study lends further evidence to a suspected link between abnormal breast growth in young boys--called prepubertal gynecomastia--and regular exposure to lavender or tea tree oil, by finding that key chemicals in these common plant-derived oils act as endocrine-disrupting chemicals.READ MORE